Gateway 2012: Stäubli - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Gateway 2012: Stäubli

Your online Gateway to Stäubli in 2012

About Stäubli

With presence in 25 countries, Stäubli is recognized worldwide for providing unrivaled quality and innovative technology. Since 1982, Stäubli has led the development of innovative solutions to improve productivity, safety, and product quality in robotics. Stäubli offers a comprehensive product range, including 4-axis SCARA and 6-axis robots for payloads of up to 250 kg. All robotic systems operate on the CS8 controller platform, which is perfectly adpated to robotics. Today, Stäubli Robotics is the leading-edge player in robotics around the world with its engineering as effective and dependable as its sales and services. Stäubli Robotics provides high performance, innovative and flexible solutions to satisfy the requirements of each industry. Designed to work in the most hostile environments as well as cleanrooms, Stäubli robots demonstrate their efficacy under all conditions.

New Products at Stäubli

The clean, precise and highly accurate range of Stericlean six axis robots provide the ideal solution to the unique set of requirements that automation in pharmaceutical, medical, and life sciences industries demand. Stericlean is the first fully VHP (Vapor Hydrogen Peroxide) resistant robot, providing fully automated operations in an isolator or cleanroom environment.





blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here